Genotype-dependent increase in plasma ACE activity after CABG is prevented by ACE inhibition

Can J Cardiol. 2003 May;19(6):701-4.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Coronary Artery Bypass*
  • Elective Surgical Procedures
  • Female
  • Genotype
  • Humans
  • Isoquinolines / therapeutic use
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A / blood*
  • Peptidyl-Dipeptidase A / genetics*
  • Quinapril
  • Tetrahydroisoquinolines*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Isoquinolines
  • Tetrahydroisoquinolines
  • Peptidyl-Dipeptidase A
  • Quinapril